Navigation Links
Epstein-Barr: a virtual look at a vexing virus

BOSTON (October 22, 2007) Researchers at Tufts University School of Medicine in collaboration with the Virginia Bioinformatics Institute at Virginia Tech have created a computer program called Pathogen Simulation (PathSim) to study the progression of Epstein-Barr virus (EBV) in humans. David Thorley-Lawson, PhD, professor of pathology at Tufts University School of Medicine, is combining PathSim, laboratory methods, and clinical studies to provide a new and powerful approach to understanding EBV and ultimately designing anti-viral therapies.

PathSim is an agent-based computer program. The agents are the virus itself, and the T and B cells of the patients immune system, explains Thorley-Lawson. Using PathSim, Thorley-Lawson can manipulate these agents to simulate EBV infection and persistence in humans. EBV can infect one person and remain latent not cause any symptoms. It can infect another person and cause infectious mononucleosis, or, in rare cases, cancer, like Hodgkins, Burkitts, and immunoblastic lymphomas, says Thorley-Lawson.

Scientists can use PathSim like a video game and change variables, such as number of virus particles or characteristics of the patients immune cells, to follow the course of disease and observe what drives the virus to either latency or illness.

We validated PathSim by comparing it to EBV infection in patients, says Thorley-Lawson. For example, PathSim projected that the peak in the number of infected immune cells, called B cells, would occur 33 through 38 days post-infection, which is consistent with the peak of 35 through 50 days actually seen in infected patients. This consistency is important because it validates the predictive power of PathSim; the power to reveal what EBV is doing in a patients body, says Thorley-Lawson.

It takes one full week to run one simulation, says Thorley-Lawson. Then we compile the data and look for critical switch points of disease. A switch point is a small change in the behavior of an agent that can influence the progression of disease. Such a change may determine whether the virus persists in the body in a latent state, or causes illness and even death by replicating out of control. Once these critical switch points are understood, biologists may be able to develop drugs that target specific points in the interaction between the virus and immune system at specific times, explains Thorley-Lawson. The more targeted the drug, the more safe and effective the resulting therapy. We hope that this marriage of computers and biology will eventually lead to better patient treatment against EBV.


Contact: Siobhan Gallagher
Tufts University, Health Sciences

Related medicine news :

1. New virtual colonoscopy procedure for easier colon screening
2. Stanford Medical Center Implements The First Virtual Cardiac Ultrasound
3. Virtual Colonoscopy May Be Better Than Real-time Colonoscopy
4. Virtual Reality For Treating Stress Disorders
5. Hip Replacement Can Now Be Performed On Virtual Patients
6. Virtual Reality Simulation Could Help In Training Surgeons
7. New Studies Show The Efficacies Of Virtual Realities Vis-à-vis Pai
8. Virtual Meeting Place Unites Patients with Brain Tumors and Neurosurgical Disorders
9. Virtual Colonoscopy in Colorectal Cancer Prevention and Screening
10. The Tech Savvy Patient Knocks on the Doors of Telemedicine and Virtual Clinics
11. Virtual Colonoscopy is Most-effective for Screening Colon Cancer
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... According to an ... changing the way that they are handling security in light of the recent terrorist ... presence in an attempt to stop an attack from reaching U.S. soil. Especially around ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... Lizzie’s Lice ... The company is offering customers 10% off of their purchase of lice treatment product. ... at full price. According to a company spokesperson. “Finding lice is a sure way ...
(Date:11/27/2015)... DE (PRWEB) , ... November 27, 2015 , ... ... member of the well-respected Microsoft Dynamics SL User Group (MSDSLUG). Recognized as Microsoft’s ... an independent group of Microsoft Dynamics SL software users, partners, industry experts and ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... most successful and prominent nonprofit healthcare organizations in the country. They have overseen ... various organizations, and helped advance the healthcare industry as a whole through their ...
(Date:11/26/2015)... Vegas, NV (PRWEB) , ... November 26, 2015 , ... ... shopping strategy. Many customers choose to buy during the Black Friday and Cyber ... gifts. Shoppers don’t need to search the Internet high and low to find the ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... Nov. 25, 2015 On Tuesday, November ... bellwether trial against Wright Medical Technology, Inc. for ... Conserve metal-on-metal hip implant device, awarded $11 million ... two week trial and three days of deliberations, ... device was defectively designed and unreasonably dangerous, and ...
(Date:11/25/2015)... Nov. 25, 2015  Henry Schein, Inc., the world,s ... office-based dental, medical and animal health practitioners, will unveil ... Henry Schein ConnectDental® Pavilion , which brings together ... open solutions designed to help any practice or laboratory ... for a schedule of experts appearing at the ...
(Date:11/25/2015)... plc (NYSE: AGN ) today announced that it has ... Attorney General,s Office to end the litigation under ... the Attorney General over the decision of Forest Laboratories, Inc., ... now generic version of memantine immediate release tablets.  Under the ... counterclaims against New York , and has ...
Breaking Medicine Technology: